Did you know fewer than 5% percent of Latinos participate in federal clinical trials? Researchers thus have less chance to develop new cancer treatments for this population, which suffers a heavy burden of certain cancers, obesity, and mental health issues. Let’s use #SaludTues on Tuesday, April 4, 2017, to tweet in English and Spanish about the latest strategies to get more Latino into clinical trials for National Minority Health Month in April 2017 and National Public Health Week April 3-9, 2017: WHAT: #SaludTues Bilingual Tweetchat: “Clinical Trials and Latinos”
TIME/DATE: 1-2 p.m. ET (Noon-1 p.m. CT), Tuesday, April 4, 2017
WHERE: On Twitter with hashtag #SaludTues
HOST: @SaludToday
CO-HOSTS: FDA Office of Minority Health (@FDAOMH), FDA En Español ...
Breast cancer patients given information about clinical trials in multiple ways, including a tailored video on breast cancer clinical trials, had much greater awareness of trials than patients who got usual-care information, according to new data. After receiving the extra information—an interactive video about clinical trials, a bilingual booklet, and access to a patient navigator who can help answer their questions—the proportion of Latina breast cancer patients taking steps toward participating in a clinical trial increased from 38% to 75%, according to the study. The study was led by researchers from the Institute for Health Promotion Research (IHPR) at UT Health San Antonio and presented at an American Association for Cancer Research (AACR) conference Nov. 9-12, 2014, in ...
Only 5% percent of Latinos participate in federal clinical trials, far less than their 19.5% makeup of the US population. This gives researchers fewer chances to find new cancer treatments for this population, which can benefit all people. What can a health agency do to get more people into clinical trials? A new guide, Clinical Trials Outreach: Program Replication Manual, developed by researchers at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio, was created to help health agencies reach into communities and increase participation in cancer clinical trials to better reflect the US population. With the guide, a health agency can: Learn about cancer clinical trials;
Learn about donation of biospecimens (human materials such as skin, hair, and ...
As a child in Arecibo, Puerto Rico, Dr. Eneida Nemecek learned the effort it takes to earn an education by literally going to college with her parents as they sought their degrees. “My parents are very young. I kind of went to college with both of them in the back of the classroom,” Nemecek said. “My dad ended up going to graduate school, also when I was still a little kid. We went to law school with him, too.” Nemecek followed her parents’ footsteps and eventually got her doctoral degree. Today she’s helping improve Latino health through clinical trial participation as associate director for clinical research at the Oregon Health & Science University (OHSU) Knight Cancer Institute and professor of pediatrics and medical oncology at OHSU.
Developing a Passion for ...
Cancer is tied with heart disease as the top cause of death for Latinos. To help us address cancer in Latinos and all people, register now for the 2026 ASCL conference on Feb. 18-20, 2026, at the Plaza San Antonio, Texas, led by the Institute for Health Promotion Research and Mays Cancer Center at UT Health San Antonio. The 2026 ASCL conference will unite cancer survivors, caregivers, researchers, doctors, and others to discuss the latest in Latino cancer research, knowledge, and action. The health of Latinos is important for the nation, where nearly one in three people are expected to be Latino within 30 years. "We hope to present timely research on every stage of the cancer continuum to improve research, clinical best practices, and community interventions," said Dr. Amelie ...
July is recognized as Sarcoma Awareness Month, which encourages communities to raise awareness and show support for those affected by sarcoma. Let’s explore resources for you and your loved ones to support!
What is Sarcoma?
Approximately 17,000 people are diagnosed with sarcoma each year in the United States. Sarcoma is a rare type of cancer that “begins in bone or in the soft tissues of the body, including cartilage, fat, muscle, blood vessels, fibrous tissue, or other connective or supportive tissue,” according to National Cancer Institute. With over 100 different subtypes, sarcomas are categorized as soft tissue or bone sarcomas, depending on where they develop in the body. Most sarcomas are within the limbs because this is where most of the body’s connective ...
The number of people living with a history of cancer in the United States is estimated at 18.6 million as of Jan. 1, 2025, according to a report on Cancer Treatment and Survivorship Statistics from the American Cancer Society (ACS). This number is projected to exceed 22 million by 2035, according to the report. Let’s dive deeper into this report and what it says about cancer survivorship.
Survivorship Stats
The ACS report highlights that the 3 most prevalent cancers among males are prostate (3,552,460) melanoma of the skin (816,580), and colorectal (729,550) For women, breast (4,305,570), uterine corpus (945,540), and thyroid (859,890) were the 3 most prevalent. “The number of female breast cancer survivors is projected to reach 5.3 million by January 1, 2035 – an ...
Dietary and lifestyle patterns can impact your cancer risk, according to a new report from the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR). The report, Dietary and lifestyle patterns for cancer prevention: evidence and recommendations from CUP Global, lists recommendations for dietary and lifestyle patterns for cancer prevention. The list has considerations for breast and colorectal cancer, the second- and third-most-common cancers worldwide. Recommendations include: For overall cancer prevention, follow a healthy dietary pattern, aim to be physically active, maintain a healthy body weight and avoid smoking. In such a dietary pattern, prioritize fruit, vegetables, and fiber-containing foods.
For colorectal cancer prevention, ...
Immune checkpoint inhibitors have been a game-changer in oncology. Tumors often have proteins on them that tell your immune system not to attack. Checkpoint inhibitors, which work by blocking these proteins so your immune system continues to fight the tumor, have provided new options for many people with advanced or metastatic cancer who were left with limited options. Patricia Moreno, Ph.D., lead of Evidence-Based Survivorship Supportive Care at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, points out that these new drugs come with unique side effects that experts still need to understand better.
The National Cancer Institute has awarded Dr. Moreno, a member of Sylvester’s Cancer Control Program, and co-investigators Jose ...
